The Lack of Standardization and Pharmacological Effect Limits the Potential Clinical Usefulness of Phytosterols in Benign Prostatic Hyperplasia

The Lack of Standardization and Pharmacological Effect Limits the Potential Clinical Usefulness of Phytosterols in Benign Prostatic Hyperplasia

The prevalence of benign prostatic hyperplasia (BPH) markedly increases with age. Phytotherapeutic approaches have been developed over time owing to the adverse side effects of conventional medications such as 5-reductase inhibitors and α1-adrenergic receptor antagonists. Therefore, dietary suppleme...

Full description

Bibliographic Details
Main Authors: Mădălina-Georgiana Buț, George Jîtcă, Silvia Imre, Camil Eugen Vari, Bianca Eugenia Ősz, Carmen-Maria Jîtcă, Amelia Tero-Vescan
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Plants
Subjects:
phytosterol
benign prostatic hyperplasia
sitosterol
campesterol
dietary supplement
Online Access:https://www.mdpi.com/2223-7747/12/8/1722

Internet

https://www.mdpi.com/2223-7747/12/8/1722

Similar Items